Lever, pancreas, slokdarm, galblaas

Future of liver disease treatment. Xenotransplantation of liver. 14

Future in esophageal cancer treatment. Precision medicine. Tumor genome sequencing. 10

How to improve health of your liver? Difficulty to keep low weight. 16

Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10

Does GERD anti-reflux surgery reduce esophageal cancer risks? The risk does not go down to zero. 2

How NASH differs from NAFLD. What drives progression to NASH? 5

Esophageal carcinoma diagnosis. PET CT. Endoscopic ultrasound. Cure at early stage is possible. 5

Esophageal carcinoma radiotherapy. ‘East’ vs. ‘West’ differences in radiotherapy use. 7

Food supplements and generic drugs for NASH and NAFLD. 8

Genetic tests to find risks for liver disease [NAFLD and NASH]. 6

Esophageal carcinoma risks and symptoms. ‘East’ vs. ‘West’ differences in esophageal cancer. 4

Gut microbiome and fatty liver disease. NAFLD, NASH, and Fecal transplantation. 7

Can fatty liver disease be reversed? NAFLD and NASH treatment. 4

Non-obese patients with NAFLD [fatty liver disease]. ‘Lean NASH’. 2

Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11

GERD anti-reflux surgery often fails after 10 years. PPI medications and esophageal cancer risk. 3

Gastroesophageal reflux disease and esophageal cancer. 1

FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15

Leading drug candidates for NASH therapy. NAFLD, fatty liver disease treatment. 12

Esophageal carcinoma. Minimally invasive surgery vs. classic surgery. Surgeon’s skill is paramount. 8

Most patients with fatty liver disease & NASH do not have symptoms. Alcohol is often not to blame. 17

Coffee reduces risks of liver disease. Coffee and NAFLD prevention. 13

When new drugs will be approved for fatty liver disease? 11

Diagnostic tests for fatty liver disease, NAFLD. FibroScan and MR Elastography. 3

Hepatic Stellate Cells cause fatty liver disease. NAFLD and NASH causes. 9

Dr. Scott L Friedman. Liver disease, NAFLD, NASH Expert. Biography. 0

Patient’s story. Metastatic esophageal cancer. Success of double neoadjuvant chemotherapy. 12

Esophageal carcinoma. Neoadjuvant chemotherapy vs. upfront surgery. 6

Dr. Jari Rasanen. Esophageal cancer and Lung cancer expert. Biography. 0

What is Non-Alcoholic Fatty Liver Disease? NAFLD Diagnostic Criteria. 1

Cancer surgery failures and challenges. Ovarian cancer. Eminent cancer surgeon.

Hypertensie bij diabetes en bij metabool syndroom. Beste behandelingsopties. 2

Screening op pancreaskanker. Screening op leverkanker. 10

MRI van de lever. MRCP van alvleesklier. MRCP of ERCP? 9

Selectie van chemotherapie voor uitgezaaide peritoneale kanker. Precisie geneeskunde selectie. 14

Hoe sceptici in werk en leven te overwinnen? Toonaangevende kankerchirurg legt uit. 9

Stadium 4 darmkanker. Lever- of longmetastasen. Locoregionale behandeling. DEBIRI TACE, IRE, SIRT. 7

Behandelingsopties voor galblaaskanker. 7

Beste chirurgische behandeling voor leverkanker. Chirurgische techniek uit Japan. 5

Alvleesklierkanker. Kwaliteit van leven hangt af van lokale controle van de tumor. 4